Dark

Check out our Level2View

CRDL
Cardiol Therapeutics Inc. Class A Common Shares
stock NASDAQ

At Close

Feb 6, 2026 3:59:30 PM EST

0.9985USD+4.010%(+0.0385)174,020

0.8600Bid 1.14Ask 0.2800Spread

Pre-market

Feb 6, 2026 9:15:30 AM EST

0.9501USD-1.031%(-0.0099)400

After-hours

Feb 6, 2026 4:31:30 PM EST

0.9884USD-1.012%(-0.0101)6,039

OverviewOptionsHistoricalExchangesShortsNews

Dec 17, 2021

10:18AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 Benzinga

07:17AM EST Cantor Fitzgerald Initiates Coverage On Cardiol Therapeutics with Overweight Rating, Announces Price Target of $8 Benzinga

Dec 3, 2021

10:17AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021 Benzinga

07:52AM EST Canaccord Genuity Initiates Coverage On Cardiol Therapeutics with Buy Rating, Announces Price Target of $8 Benzinga

Nov 3, 2021

10:18AM EDT Mid-Morning Market Update: Markets Mostly Lower; CVS Health Tops Q3 Views Benzinga

08:45AM EDT Cardiol Therapeutics Reports Pricing Of Public Offering Of 16.35 Mln Units At $3.07/unit For $50.19 Mln RTTNews

08:37AM EDT Cardiol Therapeutics Announces Pricing of Public Offering of Units PR Newswire

06:39AM EDT The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 06.15 A.M. EDT). RTTNews

Nov 2, 2021

04:05PM EDT Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed PR Newswire

Oct 18, 2021

07:28AM EDT Cardiol Therapeutics Expands LANCER, A Phase II/III Trial Of CardiolRx(TM), Into Brazil, Mexico, And Canada Benzinga

Sep 29, 2021

12:57PM EDT From BZ's Small Cap Healthcare Conference: Cardiol Therapeutics President & CEO, David Elsley Begins Speaking Benzinga

Sep 28, 2021

08:18AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive Benzinga

08:16AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments Benzinga

Sep 17, 2021

07:36AM EDT The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold Benzinga

Sep 16, 2021

07:29AM EDT Cardiol Therapeutics To Participate In Cantor Virtual Global Healthcare Conference On Sept. 28 At 8:40 a.m. EDT Benzinga

Sep 9, 2021

08:17AM EDT The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization Benzinga

Sep 8, 2021

07:32AM EDT The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod Benzinga

Aug 24, 2021

09:53AM EDT Watching Cardiol Therapeutics Shares; Hearing Raymond James Raises Price Target To $5 Benzinga

07:28AM EDT Cardiol Therapeutics Receives FDA Clearance Of Investigational New Drug Application For Phase II Clinical Trial Of CardiolRx For Acute Myocarditis Benzinga

Aug 23, 2021

12:17PM EDT EXCLUSIVE: Cardiol Therapeutics CEO, David Elsley Now Interviewing On Benzinga's Power Hour Show Benzinga

11:57AM EDT EXCLUSIVE: Cardiol Therapeutics CEO, David Elsley To Appear On Benzinga's Power Hour Show At 12:15 p.m. EDT Benzinga

08:53AM EDT Benzinga Pro's Top 5 Stocks To Watch For Monday, Aug. 23, 2021: PANW, NXTP, VVOS, TOL, CRDL Benzinga

Aug 17, 2021

05:52AM EDT The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.37 A.M. EDT). RTTNews

Share